Fate Therapeutics
Price & Volume
Stats
See moreOpen | $2.52 |
Previous Close | $2.55 |
Day Range | $2.50-$2.59 |
52W Range | $0.93-$3.23 |
Market Cap | $292.3M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $6.4M |
Revenue Growth (YoY) | 9.2% |
Gross Profit (12 Mos) | -$77.9M |
Diluted EPS | -$1.10 |
News
See moreYahoo Finance • 24 days ago
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Fate Gets FDA IND Clearance For FT839 To Initiate Phase 1/2 Trial In Autoimmune Diseases
Yahoo Finance • 2 months ago
Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate
About
CEO | Dr. Bahram Valamehr M.B.A., Ph.D. |
CFO | Mr. Kamal Adawi M.S., MBA |
Address | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 161 |